Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.91 -0.41% -0.02
INSY closed down 0.41 percent on Friday, December 14, 2018, on 1.2 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical INSY trend table...

Date Alert Name Type % Chg
Dec 14 Death Cross Bearish 0.00%
Dec 14 New 52 Week Closing Low Bearish 0.00%
Dec 14 Doji - Bullish? Reversal 0.00%
Dec 14 New 52 Week Low Weakness 0.00%
Dec 14 Wide Bands Range Expansion 0.00%
Dec 14 Oversold Stochastic Weakness 0.00%
Dec 13 New 52 Week Closing Low Bearish -0.41%
Dec 13 New 52 Week Low Weakness -0.41%
Dec 13 Wide Bands Range Expansion -0.41%
Dec 13 Oversold Stochastic Weakness -0.41%

Older signals for INSY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.0
52 Week Low 4.8
Average Volume 453,892
200-Day Moving Average 7.42
50-Day Moving Average 7.3904
20-Day Moving Average 5.9195
10-Day Moving Average 5.253
Average True Range 0.4035
ADX 46.72
+DI 8.2386
-DI 33.6732
Chandelier Exit (Long, 3 ATRs ) 6.4595
Chandelier Exit (Short, 3 ATRs ) 6.0105
Upper Bollinger Band 7.4263
Lower Bollinger Band 4.4127
Percent B (%b) 0.17
BandWidth 50.909705
MACD Line -0.7361
MACD Signal Line -0.7003
MACD Histogram -0.0358
Fundamentals Value
Market Cap 356.94 Million
Num Shares 72.7 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -22.32
Price-to-Sales 2.18
Price-to-Book 1.57
PEG Ratio -0.62
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.38
Resistance 3 (R3) 5.39 5.25 5.30
Resistance 2 (R2) 5.25 5.13 5.24 5.27
Resistance 1 (R1) 5.08 5.06 5.07 5.07 5.25
Pivot Point 4.94 4.94 4.93 4.93 4.94
Support 1 (S1) 4.77 4.82 4.76 4.76 4.57
Support 2 (S2) 4.63 4.75 4.62 4.55
Support 3 (S3) 4.46 4.63 4.52
Support 4 (S4) 4.45